N-Methyl-N-[2-[[2-[(2-Oxo-2,3-Dihydro-1H-Indole-5-Yl)Amino]-5-Trifluoromethylpyrimidin-4-Yl]Amino]Methyl]Phenyl] Methanesulfonamide N-甲基-N-[2-[[[2-[(2-氧代-2,3-二氢-1H-吲哚-5-基)氨基]-5-三氟甲基嘧啶-4-基]氨基]甲基]苯基]甲磺酰胺
CAS 717906-29-1 MFCD21608515
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Focal Adhesion Kinase (FAK), Kinase/Phosphatase Biology, Non-Receptor Tyrosine Kinase Biology, Non-Receptor Tyrosine Kinase Inhibitors, P-PH, Pfizer Compounds, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Approved Therapeutics/Drug Candidates,
相关文献及参考
- Buckbinder L, Crawford DT, Qi H, Ke HZ, Olson LM, Long KR, et al., Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc. Natl. Acad. Sci. U. S. A. 25 , 10619-24, (2007)
- Han S, Mistry A, Chang JS, Cunningham D, et al., Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design. J. Biol. Chem. 19 , 13193-201, (2009)
- Walker DP, Bi FC, Kalgutkar AS, Bauman JN, Zhao SX, et al., Trifluoromethylpyrimidine-based inhibitors of proline-rich tyrosine kinase 2 (PYK2): structure-activity relationships and strategies for the elimination of reactive metabolite formation. Bioorg. Med. Chem. Lett. 23 , 6071-77, (2008)
安全信息
GHS Symbol
- P301+P310
- P305+P351+P338
- H319 Causes serious eye irritation 严重刺激眼睛
- H301 Toxic if swallowed 吞食有毒
- S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
- S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
- R25 Toxic if swallowed 吞咽有毒
- R36 Irritating to eyes 刺激眼睛